Showing results (111-120 of 234) with videos related to

Sort By:
Pageof 24
Hematology (Amsterdam, Netherlands)|June 16, 2001
Malignancy: Changes in Circulating Immature and Mature Dendritic Cells During IL-2 Cancer Immunotherapy and Their Relation with Lymphocyte Increase and Clinical ResponsePAOLO Lissoni, ANGELA Bonfanti, VERONICA Bordin, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|February 9, 2020
Number of lung resections performed and long-term mortality rates of patients after lung cancer surgery: evidence from an Italian investigationFederico Rea, Francesca Ieva, Ugo Pastorino, et al.
Clinical Genitourinary Cancer|May 4, 2016
Cytoreductive Nephrectomy in Metastatic Renal Cell Carcinoma Treated With Targeted Therapies: A Systematic Review With a Meta-AnalysisFausto Petrelli, Andrea Coinu, Ivano Vavassori, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|December 10, 2016
Borderline resectable pancreatic cancer: More than an anatomical conceptFausto Petrelli, Alessandro Inno, Sandro Barni, et al.
Journal of Gastrointestinal Oncology|April 30, 2019
Outcome of head compared to body and tail pancreatic cancer: a systematic review and meta-analysis of 93 studiesGianluca Tomasello, Michele Ghidini, Antonio Costanzo, et al.
The Oncologist|August 12, 2018
Effectiveness of First-Line Bevacizumab in Metastatic Colorectal Cancer: The Observational Cohort Study GRETAMatteo Franchi, Sandro Barni, Giovanna Tagliabue, et al.
Minerva Medica|April 17, 2019
Treatment of venous thromboembolism with tinzaparin in oncological patientsWalter Ageno, Sandro Barni, Marcello Di Nisio, et al.
Pancreas|April 15, 2015
FOLFIRINOX-based neoadjuvant therapy in borderline resectable or unresectable pancreatic cancer: a meta-analytical review of published studiesFausto Petrelli, Andrea Coinu, Karen Borgonovo, et al.
Urology|February 21, 2016
Predictive Factors for Reclassification and Relapse in Prostate Cancer Eligible for Active Surveillance: A Systematic Review and Meta-analysisFausto Petrelli, Ivano Vavassori, Mary Cabiddu, et al.
Oncology|November 6, 2002
Postoperative hyperprolactinemia could predict longer disease-free and overall survival in node-negative breast cancer patientsMario Mandalà, Paolo Lissoni, Gianluigi Ferretti, et al.
Pageof 24